This study, called iPATH, is looking at a new way to improve care for adults with type 2 diabetes in community health centers. It's testing an approach called the "iPATH implementation approach," which is a customized, team-based, and technology-supported strategy to transform how clinics provide care. The study wants to see if this approach can help patients better manage their diabetes, specifically by improving their Hemoglobin A1c (a measure of average blood sugar over 2-3 months) levels after one year. This study is for Federally Qualified Health Centers (FQHCs) in or near Massachusetts, Ohio, California, and Puerto Rico, especially those that could benefit most from improved diabetes control. The goal is to understand what helps or hinders better diabetes care in these clinics.

Study design

This is an interventional study involving 16 community health centers, with eight starting the iPATH transformation in the first year and the other eight in the second year. The study plans to enroll a large number of participants, with a planned enrollment of 119,680.

What's involved

FQHC administrators, clinicians, and staff will participate in the iPATH transformation within their clinics and will take part in qualitative interviews. Patient HbA1c data will be collected for comparative analysis.

Compensation

Not stated in the trial record.

Follow-up

Patient Hemoglobin A1c levels will be measured before and after a one-year practice transformation period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.